September 02, 2025

Pediatric Sepsis Outcomes by EBV Serostatus

Patients who were Epstein-Barr virus seropositive showed higher levels of immune dysregulation markers.

Conexiant

September 02, 2025

Sotatercept Maintains One-Year Gains in PAH

Ongoing follow-up evaluates long-term sotatercept use in pulmonary arterial hypertension, focusing on sustained efficacy, adverse event profiles, and clinical risk classification.

Conexiant

August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

The Innovation Awards 2025: Nominate Now!

Nominations are open for The Analytical Scientist Innovation Awards 2025!

The Analytical Scientist

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant

August 27, 2025

Educational, Digital, Campaign Tools Cut Antibiotic Use

Antibiotic prescribing for common respiratory tract infections was more frequent in urgent care than in primary care, with patterns shaped by patient age and diagnosis.

Conexiant

August 26, 2025

Rituximab Linked to Weakened COVID-19 Immunity

Rituximab-treated patients with rheumatic disease had diminished antibody levels and impaired CD8+ T-cell responses after SARS-CoV-2 infection and vaccination, though CD4+ responses remained intact.

Conexiant